ResearcherTohoku UniversityNo recent work listed
Toshihiro Yoneyama
Matched on OpenAlex author ID A5017551623. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper
Papers 2
- Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-B… Co-author DOI 10.1371/journal.pone.0161009↗
- Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plasma for pancreatic cancer diagnosis. Co-author DOI 10.1021/pr3008144↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tesshi Yamada · 2 shared papers, 2013–2016 · strength 0.08
- Paper Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Comb… DOI 10.1371/journal.pone.0161009↗
- Paper Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plas… DOI 10.1021/pr3008144↗
- Tetsuya Terasaki · 2 shared papers, 2013–2016 · strength 0.08
- Paper Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Comb… DOI 10.1371/journal.pone.0161009↗
- Paper Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plas… DOI 10.1021/pr3008144↗
- Shoji Nakamori · 1 shared paper, 2016 · strength 0.04
- Tomoo Kosuge · 1 shared paper, 2016 · strength 0.04
- Tatsuya Ioka · 1 shared paper, 2016 · strength 0.04
- Naohiro Sata · 1 shared paper, 2016 · strength 0.04
- Akihiko Tsuchida · 1 shared paper, 2016 · strength 0.04
- Takuji Okusaka · 1 shared paper, 2016 · strength 0.04
- Kazufumi Honda · 1 shared paper, 2016 · strength 0.04
- Ken Ohmine · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.